Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: possible pharmacological strategies.
about
Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's diseaseChemical Analysis of Extracts from Newfoundland Berries and Potential Neuroprotective EffectsMitochondrial dysfunction induces Sarm1-dependent cell death in sensory neuronsGlobal analysis of S-nitrosylation sites in the wild type (APP) transgenic mouse brain-clues for synaptic pathology.Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors.Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD).Mechanisms of neuroprotection by protein disulphide isomerase in amyotrophic lateral sclerosis.Genetic and pharmacologic inhibition of the Ca2+ influx channel TRPC3 protects secretory epithelia from Ca2+-dependent toxicity.Altered calcium signaling following traumatic brain injuryA novel hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonist prevents ischemic neuronal deathIdentification and functional studies of a new Nrf2 partner IQGAP1: a critical role in the stability and transactivation of Nrf2.High-throughput endogenous measurement of S-nitrosylation in Alzheimer's disease using oxidized cysteine-selective cPILOT.Rotenone induces neurotoxicity through Rac1-dependent activation of NADPH oxidase in SHSY-5Y cellsBDNF and exercise enhance neuronal DNA repair by stimulating CREB-mediated production of apurinic/apyrimidinic endonuclease 1.Behavioral and neurochemical effects of proline.Mitochondrial regulation of cell cycle and proliferation.Role of p53 in neurodegenerative diseases.S-nitrosylated protein disulfide isomerase contributes to mutant SOD1 aggregates in amyotrophic lateral sclerosis.Calmodulin kinase IV-dependent CREB activation is required for neuroprotection via NMDA receptor-PSD95 disruption.1MeTIQ provides protection against Aβ-induced reduction of surface expression of synaptic proteins and inhibits H₂O₂-induced oxidative stress in primary hippocampal neurons.Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical ApplicationsParkia biglobosa improves mitochondrial functioning and protects against neurotoxic agents in rat brain hippocampal slices.Neurotensin regulates cortical glutamate transmission by modulating N-methyl-D-aspartate receptor functional activity: an in vivo microdialysis study.NR2B-containing NMDA receptors expression and their relationship to apoptosis in hippocampus of Alzheimer's disease-like rats.Crystal structure analysis and sublimation thermodynamics of bicyclo derivatives of a neuroprotector family.Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases.Neuroprotective effects of methyl-3-O-methyl gallate against sodium fluoride-induced oxidative stress in the brain of rats.Components of action potential repolarization in cerebellar parallel fibres.
P2860
Q24337079-7B23A9DB-0B65-4286-A72D-FC6ADCC01FE6Q28818617-F696D9D3-7263-4AFF-99A8-FCBB73866195Q33865342-D86ED6C4-003F-43F6-AE8A-82CC0118FB87Q34157658-C2C82C1E-1D3A-458E-8C12-EFCF31453D6AQ34497781-5A407A6A-D829-42AE-B36F-41FF1F356F64Q34979826-61B523E0-D1AF-4593-8344-199C51F20551Q34986548-D78ECCDF-EA36-40BD-ACA0-62AC91315A5DQ35028058-88D5D034-D762-4B39-9BAB-ED61CAEB9D2BQ35885083-7F50F157-A5DD-490D-85BB-E06BEC132001Q36234796-E6177831-134A-4B89-A3AC-378F7D34B57DQ36945767-076D20AC-8D56-4FCF-BEBE-8DA858DAB3E9Q36997402-9D565C1B-A44D-4E75-BA48-116B4E87815DQ37599366-4FED34B7-A68D-4549-A12F-E45CA3C98C45Q37628129-D3EC3CD0-0B54-40AE-8878-B654129B0AFAQ37885227-0F2FD9F1-E740-467D-A153-6A8620760B13Q37941864-025556AC-B22D-4D5D-8F9F-529AD5D4F99AQ37951338-D683F0DB-5626-4D33-9F58-82631E3E2D43Q39264273-65683C62-8C9C-4EE4-B179-BCECD51B7A61Q39476227-0344A9A6-AAB2-44AC-AA03-A1CC30467EFCQ40003927-2311F6CE-AB3E-46A0-AC33-DDB6C9EAFC99Q41141816-12305A04-5205-4C14-96B7-CB32E8FEA752Q42016310-BCF6AE6D-807A-479A-A690-3F44ABD203EFQ42489739-1B3DB443-A807-4B93-8ED7-7BB864816045Q42502548-70795C31-C8D9-4896-B469-D5CD7CD23B02Q44885830-D35724C5-3242-4592-AFE2-F13B1549185FQ47989317-ACE835FB-0E14-4FC3-88B0-38F53CDCE452Q48275546-8BC43EF2-339B-442B-B178-FE35C157AE33Q48529469-51F16E16-14C7-41C4-BA14-EB2B3ECBA351
P2860
Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: possible pharmacological strategies.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Preventing Ca2+-mediated nitro ...... le pharmacological strategies.
@ast
Preventing Ca2+-mediated nitro ...... le pharmacological strategies.
@en
Preventing Ca2+-mediated nitro ...... le pharmacological strategies.
@nl
type
label
Preventing Ca2+-mediated nitro ...... le pharmacological strategies.
@ast
Preventing Ca2+-mediated nitro ...... le pharmacological strategies.
@en
Preventing Ca2+-mediated nitro ...... le pharmacological strategies.
@nl
prefLabel
Preventing Ca2+-mediated nitro ...... le pharmacological strategies.
@ast
Preventing Ca2+-mediated nitro ...... le pharmacological strategies.
@en
Preventing Ca2+-mediated nitro ...... le pharmacological strategies.
@nl
P2860
P1433
P1476
Preventing Ca2+-mediated nitro ...... le pharmacological strategies.
@en
P2093
Stuart A Lipton
Tomohiro Nakamura
P2860
P304
P356
10.1016/J.CECA.2009.12.009
P577
2010-01-08T00:00:00Z